Who to call at Sonoma Pharmaceuticals, Inc., and when
Fundz watches for the moments Sonoma Pharmaceuticals, Inc. starts buying, and tells you who to reach.
- An alert the day Sonoma Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sonoma Pharmaceuticals, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sonoma Pharmaceuticals, Inc.. With Fundz connected, it knows.
Sonoma Pharmaceuticals, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
2 executive changes at Sonoma Pharmaceuticals in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.
See every company with multiple executive changes →AI Executive Summary
AI-powered analysis of 8-K filing content
Sonoma Pharmaceuticals terminated Executive Vice President and Chief Operating Officer Bruce Thornton for cause effective October 18, 2025, removing him from all Company and subsidiary positions. He will receive no pay or benefits beyond amounts earned through that date, which marks an unplanned departure of a senior operating executive.
Key Takeaways
The Company terminated COO Bruce Thornton for cause on October 18, 2025, under the terms of his employment agreement.
Thornton's removal extends to any other Company or subsidiary position he held, so he has no continuing operating role.
3 more takeaways
Related Filings (8)
8 more filings from Sonoma Pharmaceuticals, Inc. in the last 90 days
Filing Overview
What This Means
Sonoma Pharmaceuticals, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.